| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvants for cancer vaccines
|
Dubensky Jr, Thomas W.
|
|
2010
|
22 |
3 |
p. 155-161
7 p.
|
article
|
| 2 |
Adoptive transfer of unselected or leukemia-reactive T-cells in the treatment of relapse following allogeneic hematopoietic cell transplantation
|
O’Reilly, Richard J.
|
|
2010
|
22 |
3 |
p. 162-172
11 p.
|
article
|
| 3 |
Cancer vaccines: The state of the art
|
Finn, Olivera (Olja) J.
|
|
2010
|
22 |
3 |
p. 103-104
2 p.
|
article
|
| 4 |
Chemotherapy and radiotherapy: Cryptic anticancer vaccines
|
Ma, Yuting
|
|
2010
|
22 |
3 |
p. 113-124
12 p.
|
article
|
| 5 |
Corrigendum to “The role of CD40 and CD154/CD40L in dendritic cells” [Seminars Immunol. 21 (2010) 265–272]
|
Ma, Daphne Y.
|
|
2010
|
22 |
3 |
p. 190-
1 p.
|
article
|
| 6 |
Listeria and Salmonella bacterial vectors of tumor-associated antigens for cancer immunotherapy
|
Paterson, Yvonne
|
|
2010
|
22 |
3 |
p. 183-189
7 p.
|
article
|
| 7 |
Molecularly defined vaccines for cancer immunotherapy, and protective T cell immunity
|
Speiser, Daniel E.
|
|
2010
|
22 |
3 |
p. 144-154
11 p.
|
article
|
| 8 |
Polarized dendritic cells as cancer vaccines: Directing effector-type T cells to tumors
|
Kalinski, Pawel
|
|
2010
|
22 |
3 |
p. 173-182
10 p.
|
article
|
| 9 |
Tumor immunogenicity and responsiveness to cancer vaccine therapy: The state of the art
|
Schreiber, Taylor H.
|
|
2010
|
22 |
3 |
p. 105-112
8 p.
|
article
|
| 10 |
Vaccines based on abnormal self-antigens as tumor-associated antigens: Immune regulation
|
Farkas, Adam M.
|
|
2010
|
22 |
3 |
p. 125-131
7 p.
|
article
|
| 11 |
Whole tumor antigen vaccines
|
Chiang, Cheryl Lai-Lai
|
|
2010
|
22 |
3 |
p. 132-143
12 p.
|
article
|
Journal description